1
Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer
Condition(s):Breast CancerLast Updated:August 3, 2022Recruiting
Vinorelbine: 523 Clinical Trials, Page 1 of 53
Hide Studies Not Open or Pending
2
Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)
Condition(s):Locally Advanced/ Metastatic NSCLCLast Updated:December 26, 2019Unknown status
3
Vinorelbine in Advanced BRAF-like Colon Cancer
Condition(s):Colon CancerLast Updated:August 27, 2018Unknown status
4
Vinorelbine for Recurrent ALCL-2017
Condition(s):Anaplastic Large Cell Lymphoma; VinorelbineLast Updated:September 13, 2022Recruiting
5
Vinorelbine for Recurrent ACLC
Condition(s):Anaplastic Large Cell Lymphoma; VinorelbineLast Updated:July 26, 2022Completed
6
Vinorelbine in Mesothelioma
Condition(s):MesotheliomaLast Updated:October 12, 2021Completed
7
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:August 12, 2019Completed
8
A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma
Condition(s):Lung AdenocarcinomaLast Updated:August 12, 2022Terminated
9
Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas
Condition(s):Low-grade GliomaLast Updated:May 20, 2019Completed
10
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer
Condition(s):Advanced Non Small Cell Lung CancerLast Updated:February 17, 2020Completed